HSPA5 is normally retained in the ER by its KDEL motif, but in the progression of cancer, excess HSPA5 in the ER is translocated to the cell surface (csHSPA5) that stimulates the PI3K/AKT pathways, promoting promote cell survival and inhibit apoptosis14-19. Here, HSPA5 is linked to cancer.